Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2558 | 2208 | 38.3 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
1843 | 2 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO | 6139 |
2558 | 1 | ACUTE PROMYELOCYTIC LEUKEMIA//ALL TRANS RETINOIC ACID//APL | 2208 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | authKW | 4639862 | 26% | 59% | 567 |
2 | ALL TRANS RETINOIC ACID | authKW | 1041936 | 14% | 25% | 305 |
3 | APL | authKW | 988717 | 7% | 49% | 145 |
4 | ACUTE PROMYELOCYTIC LEUKAEMIA | authKW | 941788 | 4% | 70% | 98 |
5 | PML RAR ALPHA | authKW | 869223 | 4% | 71% | 89 |
6 | ATRA | authKW | 410730 | 5% | 29% | 104 |
7 | RETINOIC ACID SYNDROME | authKW | 398221 | 2% | 80% | 36 |
8 | PML RARA | authKW | 321789 | 1% | 73% | 32 |
9 | T1517 | authKW | 221226 | 1% | 67% | 24 |
10 | PROMYELOCYTIC | authKW | 197526 | 1% | 71% | 20 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 73814 | 55% | 0% | 1223 |
2 | Oncology | 15303 | 43% | 0% | 957 |
3 | Genetics & Heredity | 650 | 8% | 0% | 187 |
4 | Cell Biology | 489 | 10% | 0% | 211 |
5 | Medicine, Research & Experimental | 152 | 4% | 0% | 95 |
6 | Medicine, General & Internal | 136 | 5% | 0% | 119 |
7 | Pathology | 61 | 2% | 0% | 49 |
8 | Medical Laboratory Technology | 61 | 1% | 0% | 25 |
9 | Pediatrics | 32 | 2% | 0% | 53 |
10 | Biochemistry & Molecular Biology | 29 | 8% | 0% | 181 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SHANGHAI HEMATOL | 101380 | 2% | 15% | 48 |
2 | UMR 7212 | 62215 | 0% | 50% | 9 |
3 | NEUROONCOHEMATOL | 49156 | 0% | 44% | 8 |
4 | BIOL CELLULAIRE HEMATOPOIET | 44790 | 0% | 36% | 9 |
5 | INSERM U496 | 43208 | 0% | 63% | 5 |
6 | UMR 944 | 38406 | 0% | 56% | 5 |
7 | G HAYEM | 35388 | 0% | 32% | 8 |
8 | YONG CHUAN HOSP | 34564 | 0% | 50% | 5 |
9 | MED UNIV KLIN MANNHEIM 3 | 31603 | 0% | 57% | 4 |
10 | CNRSUPR 9051 | 31111 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA | 76238 | 9% | 3% | 204 |
2 | BLOOD | 25657 | 11% | 1% | 253 |
3 | LEUKEMIA RESEARCH | 20125 | 4% | 2% | 94 |
4 | CANCER GENETICS AND CYTOGENETICS | 16286 | 4% | 1% | 85 |
5 | BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 12883 | 1% | 3% | 28 |
6 | LEUKEMIA & LYMPHOMA | 10701 | 3% | 1% | 77 |
7 | BRITISH JOURNAL OF HAEMATOLOGY | 9344 | 4% | 1% | 96 |
8 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 5521 | 2% | 1% | 39 |
9 | ACTA HAEMATOLOGICA | 4864 | 2% | 1% | 35 |
10 | HAEMATOLOGICA | 3380 | 1% | 1% | 30 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | 4639862 | 26% | 59% | 567 | Search ACUTE+PROMYELOCYTIC+LEUKEMIA | Search ACUTE+PROMYELOCYTIC+LEUKEMIA |
2 | ALL TRANS RETINOIC ACID | 1041936 | 14% | 25% | 305 | Search ALL+TRANS+RETINOIC+ACID | Search ALL+TRANS+RETINOIC+ACID |
3 | APL | 988717 | 7% | 49% | 145 | Search APL | Search APL |
4 | ACUTE PROMYELOCYTIC LEUKAEMIA | 941788 | 4% | 70% | 98 | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA |
5 | PML RAR ALPHA | 869223 | 4% | 71% | 89 | Search PML+RAR+ALPHA | Search PML+RAR+ALPHA |
6 | ATRA | 410730 | 5% | 29% | 104 | Search ATRA | Search ATRA |
7 | RETINOIC ACID SYNDROME | 398221 | 2% | 80% | 36 | Search RETINOIC+ACID+SYNDROME | Search RETINOIC+ACID+SYNDROME |
8 | PML RARA | 321789 | 1% | 73% | 32 | Search PML+RARA | Search PML+RARA |
9 | T1517 | 221226 | 1% | 67% | 24 | Search T1517 | Search T1517 |
10 | PROMYELOCYTIC | 197526 | 1% | 71% | 20 | Search PROMYELOCYTIC | Search PROMYELOCYTIC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SANZ, MA , GRIMWADE, D , TALLMAN, MS , LOWENBERG, B , FENAUX, P , ESTEY, EH , NAOE, T , LENGFELDER, E , BUCHNER, T , DOHNER, H , ET AL (2009) MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF THE EUROPEAN LEUKEMIANET.BLOOD. VOL. 113. ISSUE 9. P. 1875 -1891 | 84 | 73% | 302 |
2 | COOMBS, CC , TAVAKKOLI, M , TALLMAN, MS , (2015) ACUTE PROMYELOCYTIC LEUKEMIA: WHERE DID WE START, WHERE ARE WE NOW, AND THE FUTURE.BLOOD CANCER JOURNAL. VOL. 5. ISSUE . P. - | 67 | 91% | 28 |
3 | LO-COCO, F , CICCONI, L , BRECCIA, M , (2016) CURRENT STANDARD TREATMENT OF ADULT ACUTE PROMYELOCYTIC LEUKAEMIA.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 172. ISSUE 6. P. 841 -854 | 61 | 91% | 5 |
4 | WANG, ZY , CHEN, Z , (2008) ACUTE PROMYELOCYTIC LEUKEMIA: FROM HIGHLY FATAL TO HIGHLY CURABLE.BLOOD. VOL. 111. ISSUE 5. P. 2505-2515 | 63 | 78% | 472 |
5 | ILAND, HJ , SEYMOUR, JF , WEI, A , (2014) OPTIMAL APPROACH FOR HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA.CURRENT OPINION IN HEMATOLOGY. VOL. 21. ISSUE 2. P. 102 -113 | 83 | 92% | 1 |
6 | NORSWORTHY, KJ , ALTMAN, JK , (2016) OPTIMAL TREATMENT STRATEGIES FOR HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA.CURRENT OPINION IN HEMATOLOGY. VOL. 23. ISSUE 2. P. 127 -136 | 69 | 99% | 1 |
7 | DE THE, H , CHEN, Z , (2010) ACUTE PROMYELOCYTIC LEUKAEMIA: NOVEL INSIGHTS INTO THE MECHANISMS OF CURE.NATURE REVIEWS CANCER. VOL. 10. ISSUE 11. P. 775 -783 | 92 | 64% | 154 |
8 | ELBAHESH, E , PATEL, N , TABBARA, IA , (2014) TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA.ANTICANCER RESEARCH. VOL. 34. ISSUE 4. P. 1507 -1517 | 83 | 85% | 2 |
9 | GRIMWADE, D , LO COCO, F , (2002) ACUTE PROMYELOCYTIC LEUKEMIA: A MODEL FOR THE ROLE OF MOLECULAR DIAGNOSIS AND RESIDUAL DISEASE MONITORING IN DIRECTING TREATMENT APPROACH IN ACUTE MYELOID LEUKEMIA.LEUKEMIA. VOL. 16. ISSUE 10. P. 1959 -1973 | 108 | 81% | 85 |
10 | MI, JQ , LI, JM , SHEN, ZX , CHEN, SJ , CHEN, Z , (2012) HOW TO MANAGE ACUTE PROMYELOCYTIC LEUKEMIA.LEUKEMIA. VOL. 26. ISSUE 8. P. 1743 -1751 | 78 | 80% | 36 |
Classes with closest relation at Level 1 |